Medical devices, healthcare technology and the business of care
510(k) clearance · K261637

Single-use Flexible Bronchoscope

Hunan Vathin Medical Instrument Co., Ltd. · Decision date Sep 23, 2026

MEDTECHLEDGER EXPLANATIONK261637

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on September 23, 2026 for K261637, a Single-use Flexible Bronchoscope submitted by Hunan Vathin Medical Instrument Co., Ltd. The application was received May 18, 2026 and reviewed under regulation 874.4680 with product code EOQ; the regulation medical specialty and review panel are both Ear, Nose, and Throat. The record describes a traditional 510(k) that was not reviewed by a third party, not a combination product, and without an authorized predetermined change control plan.

SESE in a 510(k) means the device was cleared as substantially equivalent to a legally marketed predicate; it is not a PMA approval. The available record does not identify the predicate device, the specific model or component changes, or the full indications for use. One document excerpt lists biocompatibility tests described as recommended, including cytotoxicity, irritation, sensitization, pyrogenicity, and acute systemic toxicity, but the excerpt is truncated and does not report results.

The public record does not include the decision statement or summary basis, so the clinical evidence supporting equivalence and any labeling limitations remain unknown from these sources.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Ear, Nose, Throat
Decision date
Sep 23, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261637
Regulatory pathway
510(k) premarket notification
Product code
EOQ
Decision code
SESE
Decision date
Sep 23, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Bronchoscope (Flexible Or Rigid).

Product code
EOQ
FDA device class
2

FDA decision timeline

  1. K261637 received

    Application receipt date recorded by FDA.

  2. K261637 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code EOQ

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Hunan Vathin Medical Instrument Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Xiangtan

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records